Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study.

Tomer AdarDavid M FaleckSaranya SasidharanKelly CushingNienke Z BorrenNiharika NalagatlaRyan C UngaroWayne SySamuel C OwenAnish PatelBenjamin L CohenAshwin N Ananthakrishnan

Published in: Alimentary pharmacology & therapeutics (2019)

Both anti-TNF and VDZ therapy were similarly effective and safe in elderly IBD patients.

Keyphrases